The positivity rate of Epstein-Barr virus anti-viral capsid antigen IgG among children with infectious mononucleosis in Diyala-Iraq

Mohammad Kassem Saleh; Abdulrazak Shafiq Hasan; Nadhim Ghazal Noaman

doi:10.30574/gscbps.2020.13.3.0392

Authors

Mohammad Kassem Saleh College of Medicine-Diyala University, Baqubah, Iraq.
Abdulrazak Shafiq Hasan College of Medicine-Diyala University, Baqubah, Iraq.
Nadhim Ghazal Noaman College of Medicine-Diyala University, Baqubah, Iraq.

DOI:

https://doi.org/10.30574/gscbps.2020.13.3.0392

Keywords:

Epstein-Barr virus, Infectious mononucleosis, Anti-VCA IgG

Abstract

Background: Epstein-Barr virus (EBV) is a double-stranded linear DNA human herpesvirus that is transmitted primarily through saliva during childhood. Although the majority of primary EBV infections are clinically asymptomatic, clinical cases are presented as infectious mononucleosis (IMN) syndrome.

Objectives: This study was conducted to explore the rate of EBV anti-VCA IgG among children who were clinically suspected as having IMN in Diyala province.

Subjects and methods: This is a cross sectional study that was carried out during 2018 in Diyala province- Iraq. A total of 370 blood samples were collected from 190 children under 15 years of age who were clinically suspected as having IMN, and 180 apparently healthy children as controls. The anti EBV VCA IgG antibodies were detected in serum using the VCA IgG ELISA kit (from Dia.Pro Diagnostic Bioprobes srl - Italy). Statistical analysis was carried out using the SPSS- version 25. A statistical significance was considered whenever the P value was ≤ 0.05.

Results: The results showed that the IgG positivity rate among suspected IMN patients was insignificantly higher in the age group 10-14 years old children (80.8%, P = 0.364). In control subjects the highest positivity rate was in the age group of 1-4 years with a statistically significant difference (79.5%, P = 0.002). In suspected IMN patients, the age group of 10-14 years had the highest mean concentration ± SD of anti-VCA IgG (44.018 ± 38.644 arbitrary units per milliliter (arbU/ml)), while in controls, the highest value (38.018 ± 34.908 arbU/ml) was in the age group of 1-4 years, with insignificant difference in either group (P = 0.257 and 0.072, respectively). The results also showed that in both suspected IMN patients and control subjects, females showed higher IgG positivity rate (70.6%, and 75.5%) compared to males (64.8%, and 65.1%) with insignificant difference in both groups (P = 0.392 and 0.126, respectively). Similarly, the IgG mean concentration ± SD was insignificantly higher in females in both suspected IMN patients and control subjects (P = 0.447 and 0.256, respectively). 21 (87.5%) IgM positive suspected IMN patients were also IgG positive with a statistically significant association (P = 0.028).

Conclusion: The positivity rate of anti-EBV VCA IgG among apparently healthy subjects in Diyala province was 70.6%, and the rate increases with age, with slight association with clinical suspicion of infectious mononucleosis.

Metrics

Metrics Loading ...

References

Smatti MK, Al-Sadeq DW, Ali NH, Pintus G, Abou-Saleh H, Nasrallah GK. Epstein-Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update. Front. Oncol. 2018; 8(211): 2.

Ryan KJ, Ray CG, Ahmad N, Drew WL, Lagunoff M, Pottinger P, Reller LB, Sterling CR. Sherris Medical Microbiology, 6th edition. McGraw-Hill Education. 2014.

Kliegman RM, Stanton BF, St Geme JW, Schor NF, Behrman RE. Nelson Textbook of Pediatrics, 20th edition. Elsevier, Inc. 2016.

Ralston SH, Penman ID, Strachan MW, Hobson RP. Davidson’s Principles and Practice of Medicine, 23rd edition. Elsevier, Inc. 2018.

Carroll KC, Morse SA, Mietzner T, Miller S. Jawetz, Melnick, & Adelberg’s Medical Microbiology, 27th edition. McGraw-Hill Education. 2016.

Chen Q, Hu Z, Zhang QH. Analysis of Epstein Barr virus infection in 761 hospitalized children. Chin. J. Contemp. Pediatr. 2013; 15(3): 183-6.

Sohn MJ, Cho JM, Moon JS, Ko JS, Yang HR. EBV VCA IgM and cytomegalovirus IgM dual positivity is a false positive finding related to age and hepatic involvement of primary Epstein-Barr virus infection in children. Medicine. 2018; 97(38): e12380.

Fourcade G, Germi R, Guerber F, Lupo J, Baccard M, Seigneurin A, Semenova T, Morand P, Epaulard O. Evolution of EBV seroprevalence and primary infection age in a French hospital and a city laboratory network, 2000-2016. PLoS One. 2017; 12(4): e0175574.

Balfour HH, Odumade OA, Schmeling DO, Mullan BD, Ed JA, Knight JA, et al. Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students. J. Infect. Dis. 2013; 207(1): 80-8.

Chabay PA, Preciado MV. EBV primary infection in childhood and its relation to B-cell lymphoma development: A mini-review from a developing region. Int. J. Cancer. 2013; 133(6): 1286-92.

Chen CY, Huang KYA, Shen JH, Tsao KC, Huang YCA. Large-Scale Seroprevalence of Epstein-Barr Virus in Taiwan. PLoS One. 2015; 10(1): e 0115836.

Huang Y, Wei C, Zheng K, Zhao D. The impact of serological features in Chinese children with primary of past Epstein-Barr virus infections. Virol. J. 2013; 10: 55-62.

Dunmire SK, Verghese PS, Balfour HHJr. Primary Epstein-Barr virus infection. J. Clin. Virol. 2018; 102: 84-92.

Puhakka L, Sarvikivi E, Lappalainen M, Surcel HM, Saxen H. Decrease in seroprevalence for herpesviruses among pregnant women in Finland: cross-sectional study of three time points 1992, 2002 and2012. Infect. Dis. (Lond.). 2016; 48(5): 406-10.

Linton MS, Kroeker K, Fedorak D, Dieleman L, Fedorak RN. Prevalence of Epstein-Barr Virus in a population of patients with inflammatory bowel disease: a prospective cohort study. Aliment. Pharmacol. Ther. 2013; 38(10): 1248-54.

Van Zyl DG, Mautner J, Delecluse HJ. Progress in EBV Vaccines. Front. Oncol. 2019; 9: 104.

Dowd JB, Palermo T, Brite J, et al. Seroprevalence of Epstein-Barr virus infection in U.S. children ages 6-19, 2003-2010. PLoS One. 2013; 8(5): e 64921.

Balfour HH, Sifakis F, Sliman JA, Knight JA, Schmeling DO, Thomas W. Age-Specific Prevalence of Epstein-Barr Virus Infection Among Individuals Ages 6-19 Years in the United States and Factors Affecting Its Acquisition. J. Infect. Dis. 2013; 208(8): 1286-93.

Pourahamad M, Hooshmand F, Nezhad SO, Sepidkar A. EBV seroepidemiology in married and unmarried women and men in Iran. Rep. Biochem. Mol. Biol. 2014; 2(2): 94-7.